Synthetic canonical miR-31 , a pleiotropically acting anti-metastasis miR-based therapeutic in invasive breast cancer

S. Farokhimanesh, M. Frouzandeh Moghadam, M. Ebrahimi, A. Ghamnak, Z. Hashemi



Full Text:



  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.